Biomarker Modeling

Biomarker Modeling is a quantitative pharmacometric modeling approach that characterizes and predicts the temporal behavior of biomarkers located on the causal pathway between drug exposure and clinical outcomes, thereby linking dose, pharmacokinetics, and pharmacodynamic responses within pharmacokinetic-pharmacodynamic analyses.

802

Publications

40.2K

Citations

5.3K

Authors

1.7K

Institutions

Publications per year

2017–2026

385

Authors

5.3K

  1. EF
    Enrique F. Schisterman

    Eunice Kennedy Shriver National Institute of Child Health and Human Development, United States

    11 publications · 2.2K citations

    11

    h-index

  2. LE
    Lena E. Friberg

    Uppsala University, Sweden

    8 publications · 169 citations

    8

    h-index

  3. ZF
    Ziding Feng

    Fred Hutch Cancer Center, United States

    8 publications · 418 citations

    8

    h-index

  4. YH
    Ying Huang

    Fred Hutch Cancer Center, United States

    8 publications · 278 citations

    8

    h-index

  5. MS
    Margaret S. Pepe

    Fred Hutch Cancer Center, United States

    7 publications · 590 citations

    7

    h-index

1–5 of 5.3K

Venues

  1. Statistics in Medicine

    41 publications · 4.5K citations

    21

    h-index

  2. Biometrics

    29 publications · 2K citations

    21

    h-index

  3. Clinical Pharmacology & Therapeutics

    CPT · 19 publications · 910 citations

    18

    h-index

  4. PLoS ONE

    19 publications · 784 citations

    15

    h-index

  5. CPT Pharmacometrics & Systems Pharmacology

    PSP · 22 publications · 732 citations

    15

    h-index

1–5